A transport model for the blood-brain barrier

被引:0
|
作者
Li, Guanglei [1 ]
Yuan, Wei [1 ]
Fu, Bingmei M. [1 ]
机构
[1] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA
关键词
D O I
10.1109/ISITAE.2007.4409267
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The blood-brain barrier (BBB) has unique structures in order to protect the central nervous system (CNS). In addition to the tight junction of the brain blood microvessel, there is a uniform and narrow matrix-like basement membrane layer (30-40 nm) sandwiched between the vessel wall and the astrocyte processes ensheathing the cerebral microvessel [1]. To understand the mechanism by which these structural components modulate permeability of the BBB, we developed a new mathematical model for water and solute transport across BBB. The flows in the cleft of the tight junction and in the slit between astrocyte process end feet were approximated by a Hele-Shaw channel flow while the fiber matrix layer at the luminal surface of the vessel was modeled as a Darcy medium and that in the basal lamina as a Brinkman medium. The solute transport through the BBB region was considered as a pure diffusion process. The predicted hydraulic conductivity (L(p)) is 7.2 x 10(-9) cm / s / cmH(2)O and the predicted solute permeability (P) for sodium fluorescein (NaF, MW = 376) is 6.3 x 10(-6) cm / s for the BBB in the pia mater at the surface of the CNS. The resistance from the basement membrane and astrocytes accounts for similar to 7 folds and similar to 4 folds of those from the vessel wall components for L(p) and p(NaF), respectively. Our results suggest that they are significant contributors in maintaining low BBB permeability.
引用
收藏
页码:189 / 190
页数:2
相关论文
共 50 条
  • [21] Drug transport across the blood-brain barrier
    Fricker, G
    PHARMACOKINETIC CHALLENGES IN DRUG DISCOVERY, 2002, 37 : 139 - 154
  • [22] Drug transport across the blood-brain barrier
    Pardridge, William M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (11): : 1959 - 1972
  • [23] Saturable transport of gabapentin at the blood-brain barrier
    Luer, MS
    Hamani, C
    Dujovny, M
    Gidal, B
    Cwik, M
    Deyo, K
    Fischer, JH
    NEUROLOGICAL RESEARCH, 1999, 21 (06) : 559 - 562
  • [24] The transport of manganese across the blood-brain barrier
    Aschner, M
    NEUROTOXICOLOGY, 2006, 27 (03) : 311 - 314
  • [25] Active transport of fentanyl by the blood-brain barrier
    Henthorn, TK
    Liu, Y
    Mahapatro, M
    Ng, KY
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (02): : 1084 - 1089
  • [26] Lipid transport across the blood-brain barrier
    Cecchelli, R
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (04) : D126 - D127
  • [27] Transport of ethylmercury and methylmercury in an in vitro blood-brain barrier model.
    Walker, S. J.
    Nelson, A.
    Blaxill, M.
    Aschner, M.
    NEUROTOXICOLOGY, 2006, 27 (06) : 1185 - 1185
  • [28] Regulation of Insulin Blood-Brain Barrier Transport
    Nguyen, V. Q.
    Thomas, P.
    Rhea, E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S296 - S297
  • [29] Blood-Brain Barrier Transport of Opioid Analgesics
    Suzuki, Toyofumi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (10): : 1445 - 1451
  • [30] Transport of xenobiotics across the blood-brain barrier
    Hagenbuch, B
    Gao, B
    Meier, PJ
    NEWS IN PHYSIOLOGICAL SCIENCES, 2002, 17 : 231 - 234